Diagnostic utility of bipolar precordial leads during ajmaline testing for suspected Brugada syndrome

Heart Rhythm

Volumn 7, Issue 2, 2010, Pages 208-215

  Batchvarov, Velislav N ^a   Govindan, Malini ^a   Macfarlane, Peter ^b   Camm, A John ^a   Behr, Elijah R ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Ajmaline test; Bipolar lead; Brugada syndrome; Electrocardiography; Precordial lead; Ventricular arrhythmia; Ventricular repolarization

Indexed keywords

AJMALINE;

ACTION POTENTIAL; ADULT; ARTICLE; BRUGADA SYNDROME; CONTROLLED STUDY; DIAGNOSTIC VALUE; ECG ABNORMALITY; ELECTROCARDIOGRAPHY; FEMALE; HEART ARREST; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SUDDEN DEATH;

ADULT; AJMALINE; ANTI-ARRHYTHMIA AGENTS; BRUGADA SYNDROME; CHI-SQUARE DISTRIBUTION; ELECTROCARDIOGRAPHY; ELECTRODES; FEMALE; HUMANS; MALE; SENSITIVITY AND SPECIFICITY;

EID: 74449084738     PISSN: 15475271     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.10.005     Document Type: Article

References (33)

1. Brugada P., and Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. J Am Coll Cardiol 20 (1992) 1391-1396
2. Wilde A.A.M., Antzelevitch C., Borggrefe M., et al. Consensus report. Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J 23 (2002) 1648-1554
3. Antzelevitch C., Brugada P., Borggrefe M., et al. Brugada syndrome. Report of the Second Consensus Conference. Circulation 111 (2005) 659-670
4. Benito B., Brugada R., Brugada J., and Brugada P. Brugada syndrome. Prog Cardiovasc Dis 51 (2008) 1-22
5. Roesler H. An electrocardiographic study of high take-off of the R(R′)-T segment in right precordial leads. Am J Cardiol 6 (1960) 920-928
6. Shimizu W., Matsuo K., Takagi M., et al. Body surface distribution and response to drugs of ST segment elevation in Brugada syndrome: clinical implication of eighty-seven-lead body surface potential mapping and its application to twelve-lead electrocardiograms. J Cardiovasc Electrophysiol 11 (2000) 396-404
7. Sangwatanaroj S., Prechawat S., Sunsaneewitayakul B., Sitthisook S., Tosukhowong P., and Tungsanga K. New electrocardiographic leads and the procainamide test for the detection of the Brugada sign in sudden unexplained death syndrome survivors and their relatives. Eur Heart J 22 (2001) 2290-2296
8. Teijeiro R., Garro H.A., Acunzo R.S., Albino E., and Chiale P.A. Recording of high V1-V3 precordial leads may be essential to the diagnosis of Brugada syndrome during the ajmaline test. J Cardiovasc Pharmacol Ther 11 (2006) 153-155
9. Nakazawa K., Sakurai T., Takagi A., et al. Clinical significance of electrocardiography recordings from a higher intercostal space for detection of the Brugada sign. Circ J 68 (2004) 1018-1022
10. Meregalli P.G., Ruijter J.M., Hofman N., Bezzina C.R., Wilde A.A.M., and Tan H.L. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 17 (2006) 857-864
11. Miyamoto K., Yokokawa M., Tanaka K., et al. Diagnostic and prognostic value of a type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men With Brugada syndrome. Am J Cardiol 99 (2007) 53-57
12. Brugada P. Amid the fourth lustrum after the description of Brugada syndrome: controversies over?. Europace 11 (2009) 412-413
13. Watanabe H., Koopmann T.T., Le Scouarnec S., et al. Sodium channel β1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest 118 (2008) 2260-2268
14. Morita M., Zipes D.P., and Wu J. Brugada syndrome: insights of ST elevation, arrhythmogenicity, and risk stratification from experimental observations. Heart Rhythm 6 (2009) S34-S43
15. Yan G.-X., and Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation. Circulation 100 (1999) 1660-1666
16. Yan G.-X., Shimizu W., and Antzelevitch C. Characteristics and distribution of M cells in arterially perfused canine left ventricular wedge preparations. Circulation 98 (1998) 1921-1927
17. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 12 (2001) 268-272
18. Kurita T., Shimizu W., Inagaki M., et al. The electrophysiologic mechanism of ST-segment elevation in Brugada syndrome. J Am Coll Cardiol 40 (2002) 330-334
19. Shimizu W., Aiba T., Kurita T., and Kamakura S. Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation. J Cardiovasc Electrophysiol 12 (2001) 1418-1421
20. Narayan S.M., Kim J., Tate C., and Berman B.J. Steep restitution of ventricular action potential duration and conduction slowing in human Brugada syndrome. Heart Rhythm 4 (2007) 1087-1089
21. Aiba T., Shimizu W., Hidaka I., et al. Cellular basis for trigger and maintenance of ventricular fibrillation in the Brugada syndrome model high-resolution optical mapping study. J Am Coll Cardiol 47 (2006) 2074-2085
22. Lambiase P.D., Ahmed A.K., Ciaccio E.J., et al. High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. Circulation 120 (2009) 106117
23. Nagase S., Kusano K.F., Morita H., et al. Longer repolarization in the epicardium at the right ventricular outflow tract causes type 1 electrocardiogram in patients with Brugada syndrome. J Am Coll Cardiol 51 (2008) 1154-1161
24. Coronel R., Casini S., Koopmann T.T., et al. Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome. A combined electrophysiological, genetic, histopathologic, and computational study. Circulation 112 (2005) 2769-2777
25. Nagase S., Kusano K.F., Morita H., et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome. Using the epicardial lead. J Am Coll Cardiol 39 (2002) 1992-1995
26. Furushima H., Chinushi M., Hirono T., et al. Relationship Between dominant prolongation of the filtered QRS duration in the right precordial leads and clinical characteristics in Brugada syndrome. J Cardiovasc Electrophysiol 16 (2005) 1311-1317
27. Huang Z., Patel C., Li W., et al. Role of signal-averaged electrocardiograms in arrhythmic risk stratification of patients with Brugada syndrome: a prospective study. Heart Rhythm 6 (2009) 1156-1162
28. Morita H., Kusano K.F., Miura D., et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation 118 (2008) 1697-1704
29. Meregalli P.G., Wilde A.A.M., and Tan H.L. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more?. Cardiovasc Res 67 (2005) 367-378
30. Chinushi M., Izumi D., Furushima H., Watanabe H., and Aizawa Y. Multiple premature beats triggered ventricular arrhythmias during pilsicainide infusion in a patient with inferior ST-segment elevation. Pacing Clin Electrophysiol 29 (2006) 1445-1448
31. Riera A.R., Ferreira C., Schapachnik E., Sanches P.C., and Moffa P.J. Brugada syndrome with atypical ECG: downsloping ST-segment elevation in inferior leads. J Electrocardiol 37 (2004) 101-104
32. Rautaharju P., and Rautaharju F. Investigative Electrocardiography in Epidemiological Studies and Clinical Trials. London: Springer-Verlag (2007) 18-28
33. Macfarlane P.W. Age, sex, and the ST amplitude in health and disease. J Electrocardiol 4 Suppl (2001) 235-241